Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
After finishing at $0.09 in the prior trading day, Syros Pharmaceuticals Inc (NASDAQ: SYRS) closed at $0.09, down -7.14%. In other words, the price has decreased by -$7.14 from its previous closing price. On the day, 8.16 million shares were traded. SYRS stock price reached its highest trading level at $0.0998 during the session, while it also had its lowest trading level at $0.0853.
Ratios:
Our goal is to gain a better understanding of SYRS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.25 and its Current Ratio is at 2.25.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, H.C. Wainwright on November 04, 2020, Upgraded its rating to Buy and sets its target price to $15 from $11 previously.
On September 22, 2020, Alliance Global Partners started tracking the stock assigning a Buy rating and target price of $18.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 14 ’25 when Fanucci Marsha bought 9,333 shares for $0.10 per share.
WIRTH PETER bought 9,333 shares of SYRS for $2,008 on Mar 11 ’25. On Dec 27 ’24, another insider, Flagship Pioneering Fund VII, , who serves as the Affiliate of the company, bought 1,135,308 shares for $0.24 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SYRS now has a Market Capitalization of 2302228 and an Enterprise Value of 4253225. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.90. Its current Enterprise Value per Revenue stands at 11.019 whereas that against EBITDA is -0.039.
Stock Price History:
The Beta on a monthly basis for SYRS is 1.65, which has changed by -0.9861958 over the last 52 weeks, in comparison to a change of 0.09589827 over the same period for the S&P500. Over the past 52 weeks, SYRS has reached a high of $6.93, while it has fallen to a 52-week low of $0.07. The 50-Day Moving Average of the stock is -49.65%, while the 200-Day Moving Average is calculated to be -96.05%.
Shares Statistics:
The stock has traded on average 16.92M shares per day over the past 3-months and 90430350 shares per day over the last 10 days, according to various share statistics. A total of 26.83M shares are outstanding, with a floating share count of 23.67M. Insiders hold about 11.80% of the company’s shares, while institutions hold 8.27% stake in the company. Shares short for SYRS as of 1740700800 were 939583 with a Short Ratio of 0.06, compared to 1738281600 on 723199. Therefore, it implies a Short% of Shares Outstanding of 939583 and a Short% of Float of 3.81.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
